Current status of oral anticancer drugs in Japan

Comment

Y Fujiwara. J Clin Oncol. 1999 Oct.

. 1999 Oct;17(10):3362-5.

doi: 10.1200/JCO.1999.17.10.3362.

No abstract available

Comment on

Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery.
Wada H, Hitomi S, Teramatsu T. Wada H, et al. J Clin Oncol. 1996 Apr;14(4):1048-54. doi: 10.1200/JCO.1996.14.4.1048. J Clin Oncol. 1996. PMID: 8648356 Clinical Trial.
Oral chemotherapy: rationale and future directions.
DeMario MD, Ratain MJ. DeMario MD, et al. J Clin Oncol. 1998 Jul;16(7):2557-67. doi: 10.1200/JCO.1998.16.7.2557. J Clin Oncol. 1998. PMID: 9667278 Review.
Uracil-tegafur in gastric carcinoma: a comprehensive review.
Takiuchi H, Ajani JA. Takiuchi H, et al. J Clin Oncol. 1998 Aug;16(8):2877-85. doi: 10.1200/JCO.1998.16.8.2877. J Clin Oncol. 1998. PMID: 9704742 Review.
Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women.
Fossati R, Confalonieri C, Torri V, Ghislandi E, Penna A, Pistotti V, Tinazzi A, Liberati A. Fossati R, et al. J Clin Oncol. 1998 Oct;16(10):3439-60. doi: 10.1200/JCO.1998.16.10.3439. J Clin Oncol. 1998. PMID: 9779724
Uracil-ftorafur: an oral fluoropyrimidine active in colorectal cancer.
Sulkes A, Benner SE, Canetta RM. Sulkes A, et al. J Clin Oncol. 1998 Oct;16(10):3461-75. doi: 10.1200/JCO.1998.16.10.3461. J Clin Oncol. 1998. PMID: 9779725 Review.